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Oxidative stress results when the balance between the production of reactive oxygen species
(ROS) overrides the antioxidant capability of the target cell; oxidative damage from the interaction
of reactive oxygen with critical cellular macromolecules may occur. ROS may interact with and
modify cellular protein, lipid, and DNA, which results in altered target cell function. The
accumulation of oxidative damage has been implicated in both acute and chronic cell injury
including possible participation in the formation of cancer. Acute oxidative injury may produce
selective cell death and a compensatory increase in cell proliferation. This stimulus may result in
the formation of newly initiated preneoplastic cells and/or enhance the selective clonal expansion
of latent initiated preneoplastic cells. Similarly, sublethal acute oxidative injury may produce
unrepaired DNA damage and result in the formation of new mutations and, potentially, new
initiated cells. In contrast, sustained chronic oxidative injury may lead to a nonlethal modification
of normal cellular growth control mechanisms. Cellular oxidative stress can modify intercellular
communication, protein kinase activity, membrane structure and function, and gene expression,
and result in modulation of cell growth. We examined the role of oxidative stress as a possible
mechanism by which nongenotoxic carcinogens may function. In studies with the selective
mouse liver carcinogen dieldrin, a species-specific and dose-dependent decrease in liver
antioxidant concentrations with a concomitant increase in ROS formation and oxidative damage
was seen. This increase in oxidative stress correlated with an increase in hepatocyte DNA
synthesis. Antioxidant supplementation prevented the dieldrin-induced cellular changes. Our
findings suggest that the effect of nongenotoxic carcinogens (if they function through oxidative
mechanisms) may be amplified in rodents but not in primates because of rodents' greater
sensitivity to ROS. These results and findings reported by others support a potential role for
oxidative-induced injury in the cancer process specifically during the promotion stage. Environ
Health Perspect 106(Suppl 1):289-295 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/
289-295klaunig/abstract.html
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Introduction
Oxidative stress occurs in a cell or tissue metabolism and oxidative phosphorylation.
when the concentration ofreactive oxygen The metabolism ofsubstances by the P450
species (ROS) generated exceeds the antioxi- enzyme system generates oxygen free radicals
dant capability ofthat cell (1). ROS can be through normal orfutile cyclingmechanisms
produced both endogenously or exoge- (2). Exogenous sources of ROS can also
nously (Figure 1). Endogenous oxidative impact on the overall oxidative status ofa
stress can be the result ofnormal cellular cell. Drugs, hormones, and other xenobiotic
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chemicals can produce ROS by either direct
or indirect mechanisms (3,4). Alternatively,
oxidative stress can also occurwhen there is a
decrease in the antioxidant capacity ofa cell.
Nonenzymatic antioxidant levels (vitamin E,
vitamin C, glutathione, etc.) and enzymatic
antioxidant levels (superoxide dismutase,
glutathione peroxidase, and catalase) in the
cell can be decreased through modification
in gene expression, decreased in their uptake
in the diet, or can be overloaded in ROS
production, which creates a net increase in
the amount ofoxygen free radicals present in
thecell (5,6).
Several human chronic disease states
including cancer have been associated with
oxidative stress produced through either an
increased free radical generation and/or a
decreased antioxidant level in the target
cells and tissues (4,7). A role for reactive
oxygen radicals in the etiology ofcancer is
supported by epidemiologic studies.
Specifically these epidemiologic studies
illustrated the protective role for antioxi-
dants against cancer development (8,9) and
a correlation between tumor induction and
the intake ofhigh concentrations oftransi-
tion metals such as iron, which facilitate the
production offree radicals (10,11).
Oxidative Damage in DNA,
Lipid, andProtein
The formation ofoxidative stress may result
in damage to critical cellular macromolecules
including DNA, lipids, and proteins.
Oxidative DNA damage may participate in
ROS-induced carcinogenesis (12). A com-
mon form ofdamage is the formation of
hydroxylated bases ofDNA, which are con-
sidered an important event in chemical car-
cinogenesis (12,13). This adduct formation
interfereswith normal cell growth bycausing
genetic mutations and altering normal gene
transcription. Several different pathways by
which oxidative DNA damage leads to
mutations have been proposed, including
chemical modification ofnucleotide moieties
in DNAcausing alteration in their hydrogen
bonding, exacerbation ofpolymerase-specific
hot spots, conformational change in the
DNA templates, and the induction of a
DNA polymerase conformation that is error
prone (14). Formation of 8-hydroxy-2'-
deoxyguanosine (8-OHdG) [an oxidative
modification ofDNAproduced byhydroxy-
lation in the C-8 position ofdeoxyguanosine
residues by the hydroxyl radical (15)] has
been used as a measurement ofoxidative
DNAdamage.
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Figure 1. Reactive oxygen species production and dis-
ruption of cellular homeostasis. ROS can be produced
by both endogenous and exogenous sources. An over-
load of the normal antioxidant defense system by
these reactive oxygen molecules will result in oxidative
stress and eventual oxidative damage to critical cellu-
lar macromolecules. Abbreviations: CAT, catalase;
GSH, reduced glutathione; GSHperox, reduced glu-
tathione peroxidase; SOD, superoxide dismutase; VitC,
vitamin C; VitE, vitamin E.
Cellular fatty acids are readily oxidized
by ROS to produce lipid peroxyl radicals
and lipid hydroperoxides (7). Lipid per-
oxyl radicals can subsequently propagate
into malondialdehyde (MDA). The forma-
tion oflipid damage (lipid peroxidation)
may result in several possible sequelae
including protein oxidation (7). These
lipid radicals can diffuse through mem-
branes, thus modifying the structure and
function ofthe membrane and resulting in
a loss ofcell homeostasis. In addition, lipid
peroxides may result in the interaction
with cellular DNA and cause the formation
ofDNA-MDA adducts (13).
Proteins are also easily attacked by ROS
directly or indirectly through lipid peroxi-
dation. Protein radicals can be rapidly
transferred to other sites within the protein
infrastructure. This can result in further
modification of enzyme activity (stimula-
tion or inhibition) (16,17). In addition to
enzymes, damage to the membrane trans-
port proteins may produce cellular ionic
homeostasis and lead to alterations in
intercellular calcium and potassium that
will trigger a series ofchanges in cells (18).
Changes to receptor proteins and gap junc-
tion proteins may also modify signal trans-
fer in cells. In selective cases alteration of
protein structure may allow the target pro-
tein to be further attacked by proteinases
(19). Thus protein oxidative damage can
result in the modifications in structure,
enzyme activity, and signaling pathways.
OtherTargets ofOxidative Stress
Activation of transcription factors is an
important signaling pathway for the regu-
lation ofgene transcription by ROS (20).
Transcription factors are low-molecular-
weight proteins that can bind with the pro-
moter region of a gene. Transcription
factors regulate the transcription ofgenes
involved in the development, growth, and
aging ofcells (21). The regulation ofsub-
cellular localization from cytoplasm to
nuclear is first step of transcription factor
activity (22). Oxidative stress is believed to
be involved in this process. Nuclear factor
kappa B and AP-1, by direct oxidation and
phosphorylation, are two transcription fac-
tors that are modulated by oxidative stress
(23). The AP-1 transcription factor is a
dimer ofa protein complexjoined by c-fos,
c-jun, jun-B and jun-D. AP-1 controls
genes required for cell growth and its activ-
ity is increased by compounds that induce
cellular proliferation. ROS can cause acti-
vation ofAP-1 as well as new synthesis of
AP-1 (18). Oxidative stress can also induce
the immediate early protooncogenes
c-fos, jun-B, c-jun, and jun-D, and thus
increase AP-1 transcription factor activity.
Therefore ROS may play a central role in
signal transfer system. High levels ofROS
may alter signal pathways by oxidative
damage of the cell membrane, changes in
enzyme activity, and/or the activation of
transcription factors. These alterations
may be important links between xenobi-
otic exposure and tumorigenesis. The
effects of ROS in stimulating cell growth
have been seen in vitro. ROS regulate
genes via protein kinase C (PKC) activa-
tion, oxidative damage, and/or ROS
direct activation of transcription factors
(14,20,24). The mediation of ROS on
gene transcription may also inhibit normal
cell apoptosis by modulation of myc, bcl-2
and p53 expression and result in an
increase in cell number.
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Chemically induced cancer is a multistage
process definable by at least three steps or
stages: initiation, promotion, and progres-
sion (Figure 2). The tumor promotion
stage involves the selective clonal expansion
of the initiated cell population through
either increased cell division and/or
decrease cell death (apoptosis) (25,26).
The final stage (progression) involves the
development of irreversible cancer growth
from the preneoplastic lesions (27).
Initiation involves a nonlethal and
inheritable mutation in cells by interaction
of a chemical with DNA. This mutation
confers a growth advantage to that cell. For
the mutation to be set a round of DNA
synthesis must occur to lock in the muta-
tion. The activation of the carcinogen to
an electrophilic DNA-damaging moiety is
a necessary step for this stage. ROS are
believed to mediate the activation ofsuch
carcinogens through hydroperoxide-depen-
dent oxidation that can be mediated by
peroxyl radicals (4). This occurs with afla-
toxin B,, aromatic amines, and polycyclic
aromatic hydrocarbon dihydrodiols (4).
ROS or their byproduct oflipid peroxida-
tion, MDA, can also directly react with
DNA to form oxidative DNA adducts
(13). The presence of carcinogen-DNA
adducts and oxidative DNA adducts gener-
ated by chemical carcinogens suggest an
interactive role ofROS in initiation. ROS,
therefore, can have multiple effects in the
initiation stage of carcinogenesis by medi-
ating carcinogen activation, causing DNA
damage, and interfering with the repair of
the DNAdamage (Figure 3).
Promotion involves the selective clonal
expansion of the initiated cell population
through either increased cellular prolifera-
tion and/or inhibition ofcell death (apop-
tosis). Pathologically this results in the
formation ofthe preneoplastic lesion (foci
from the initiated cell). ROS are specifically
Apoptosis
I- Growth
advantage
and genetic > ~ instability
Proliferation
Normal cell Altered cell Initiated cell Focal lesion
Initiation Promotion
Cancer
Progression
Figure 2. Multistage process of cancer. Cancer involves the formation of an altered cell that becomes a mutated
initiated cell after a round of DNA synthesis. This initiated cell may clonally grow through either the induction of
cell proliferation or the inhibition of apoptosis to a focal lesion. Subsequent additional DNA damage and genetic
instability may allow selective focal lesions to progress to the neoplastic stage.
Environmental Health Perspectives * Vol 106, Supplement 1 * February 1998 290OXIDATIVE STRESS IN NONGENOTOXIC HEPATOCARCINOGENESIS
DNA damage: GJIC Abnormal Abnormal Resistenceto
gene mutation, inhibition gene enzyme chemotherapy structure alteration expression activity
proliferation Aptoi
| Inheritable mutation | lnal expansion ||Metastasisand invasion|
Initiation stage - Promotion stage - Progression stage
Figure 3. Oxidative stress interacts with all three stages of the cancer process. During the initiation stage oxidative
DNA damage may produce gene mutations and structural alterations of the DNA, resulting in a heritable mutation.
During the promotion stage ROS and oxidative stress can contribute to abnormal gene expression, blockage of cell-to-
cell communication, and modification of second messenger systems, resulting in an increase in cell proliferation or a
decrease in apoptosis in the initiated cell population. This results in the clonal expansion of the initiated cells to pre-
neoplastic focal lesions. Oxidative stress mayalso participate inthe progression stage ofthe cancer process by impart-
ing further DNAalterations tothe initiated cell population. These changes mayresult in changes in enzyme activityand
makethe lesions resistantto normal growth control. Abbreviation: GJIC, gapjunctional intercellular communication.
generated in initiated cell populations such
as preneoplastic foci in liver. Because ROS
generation is related to P450 enzyme activ-
ity, oxidative stress may have an important
role in the clonal expansion ofthese initi-
ated cells. In fact, higher levels ofROS have
been found in neoplastic nodules ofrat liver
than in the surrounding normal tissue; phe-
nobarbital treatment enhanced this forma-
tion by increasing the mono-oxygenase
system in the nodules (28). Another sug-
gested source ofROS is from the oxidation
ofglutathione by y-glutymyltranspeptidase
in preneoplastic foci (29). Extracellular
sources ofROS may come from inflamma-
tory cells. The accumulation ofneutrophils
following topical application ofboth phor-
bol and nonphorbol tumor promoters in
skin has been reported (30). These multiple
sources ofROS may contribute to a persis-
tent oxidative stress environment that
results in pathophysiologic changes
and allows for the selective growth of
preneoplastic initiated cells (Figure 3).
Tumor progression results in the
development of malignant growth from
benign lesions. In this stage oxidative
stress may play a direct role in the devel-
opment of cancer characteristics such as
uncontrolled growth, genomic instability,
chemotherapy resistance, and invasion and
metastasis. Tumor cells continually
undergo high and persistent oxidative
stress, as was shown bythe measurement of
higher 8-OHdG levels in human carci-
noma cells than in surrounding normal
cells (31). This persistent oxidative stress
does not appear large enough to induce cell
death because tumor cells have a decreased
cell sensitivity to oxidative stress (31,32).
Cancer cells emerging from the multistep
carcinogenic process with inactivated or
deleted tumor-suppressor genes and/or
activated oncogenes are much less depen-
dent than normal cells on external growth
factors because they can manufacture their
own factors. High antioxidants induced by
persistent oxidative stress in cancer cells
increase the chemotherapy resistance ofthe
cells. Increased protein oxidative damage
on certain protease inhibitors facilitates
tumor invasion (31) (Figure 3).
Results and Discussion
Dieldrin: ACaseStudy
We are interested in understanding the
mechanism by which nongenotoxic epige-
netic carcinogens function. These com-
pounds appear to have multiple effects at the
target cell depending on the compound
involved. These changes include modifica-
tion to cell function such as alterations of
gap junction intercellular communication,
induction ofperoxisomes, activation of
PKC, modification of gene expression,
induction oftranscription factors, and/or
modulation ofoxidative stress. It is impor-
tant to note that whereas these toxic end
points are seen following exposure to
nongenotoxic epigenetic carcinogens, the
mechanism by which these compounds
induced their cancer remains unresolved and
may involve one or more ofthese important
effects. Wewill focus on the roleand mecha-
nism by which the organochlorine pesticide
dieldrin selectively induces hepatic cancer in
the mouse (33). Dieldrin is a unique com-
pound in that its carcinogenic effect is
restricted to the formation ofhepatic tumors
following chronic feeding in the mouse
(34,35). Other species, including the rat,
dog, and monkeyare resistant to thecarcino-
genic effects ofdieldrin. Previous studies
showed that the metabolism ofdieldrin in
the mouse and rat was very similar (36).
Thus the mechanism for the selective induc-
tion ofhepatic cancer by dieldrin in mice
does not appear related to differences in
dieldrin metabolism or pharmacokinetics
between the twospecies.
In an effort to further understand the
mechanisms ofdieldrin induction ofcancer
in the mouseliver, our initial studies concen-
trated on examining the role ofdieldrin in
induction ofcell proliferation and/or modu-
lation ofcell death (apoptosis). The induc-
tion ofcellular proliferation has been linked
to thecarcinogenic potential ofacompound.
It appears that induction ofcellularprolifera-
tion in target tissue is a common propertyof
most nongenotoxic carcinogens. Our initial
studies (37,38) used a 90-day in vivo bioas-
sayinwhich dieldrin (at 10, 1, and 0.1 ppm)
was examined for its ability to selectively
induce hepatic DNA synthesis in the mouse
liver. Male F344 rats and male B6C3F1
mice were sampled after 7, 14, 28, and 90
days ofcontinuous treatment with dieldrin
in the diet. The results ofthis study showed
that dieldrin induced an increase in DNA
synthesis that was dose dependent and seen
only in the mouse (Figure 4A). Dieldrin had
no effect on DNA synthesis in the similarly
treated rats (Figure 4B). 'Whereas an increase
in DNA synthesis was seen at all sampling
times in the mouse liver at the highest dose
studied, the largest effect was seen after 14
days ofcontinuous treatment. The dieldrin
doses chosen for study correlated with those
used in the previously performed chronic
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Figure 4. Dieldrin and hepatocyte labeling index effects. The effect of dieldrin at three concentratio
and 10 mg/kg) on the hepatocyte labeling index in male (A) B6C3F1 mouse liver and (B) F344 rat liver
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hepatocyte labeling in the mouse liver but did not produce a significant increase in hepatocyte labelir
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Figure 5. The effect of dieldrin atthree concentrations (0.1, 1.0, 10 mg/kg) on hepatocyte labeling index in diethyl-
nitrosamine-induced hepatic foci male B6C3F1 mouse liver (A) and male F344 rat liver (B) was examined after 7,
30, and 60 days of treatment. Dieldrin produced a dose-dependent increase in hepatocyte labeling in the mouse
hepatic foci at all times examined. Dieldrin failed to produce an increase in hepatocyte labeling in the rat hepatic
foci at all times examined.
carcinogenicity bioassay. Interestingly, those
doses that induced cancer in the long-term
bioassay (10 and 1 ppm) also induced an
increase in DNA synthesis in the present
investigation. The dose that failed to pro-
duce a carcinogenic response following long-
term treatment (0.1 ppm) did not induce a
statistical increase in DNA synthesis in the
subchronic study.
In addition to the above studies, the
question arose as to whether the unique
hepatocarcinogenic effect ofdieldrin in the
mouse was attributed to a tumor promotion
activity ofthe dieldrin and specifically to the
mouse. More specifically, the question was
raised whether the mouse by its nature of
having a greater population ofinitiated pre-
neoplastic hepatocytes was more susceptible
to the promotional effects ofnongenotoxic
carcinogens such as dieldrin. Ifthat were the
case then a rat with a similar preneoplastic
initiated hepatocyte population would show
a similar tumor induction or promotion
response to dieldrin exposure as the mouse.
An alternative hypothesis would be that a
uniqueness of mouse liver biology made it
more susceptible to dieldrin carcinogenicity
and that this uniqueness would be carried
90
vys
ns (0.1, 1.0,
was exam-
in both preneoplastic initiated cells and
normal cells. To answer these questions a
model system was developed to produce
preneoplastic initiated cells in mouse and
rat liver. The carcinogen diethylnitrosamine
was used to produce preneoplastic hepatic
foci in both rats and mice. Using this pro-
tocol the diethylnitrosamine was given to
rats and mice soon after weaning for a short
duration. Four months after diethylni-
trosamine treatment, the animals were
placed on a diet containing dieldrin with
the same concentrations used in the sub-
chronic study noted above (10.0, 1.0, and
0.1 ppm). Animals were treated with dield-
rin for either 7, 30, or 60 days and sampled
at each of these time periods. Livers were
excised and hepatic DNA synthesis, hepatic
apoptosis, lesion size and volume, and
increase in lesion morphology were quantitated in
ng in the rat dieldrin-treated and control untreated rats
and mice. Dieldrin induced an increase in
DNA synthesis (Figure 5A), had no effect
eated on apoptosis (39), and induced an increase
Irin,0.1mg/kg in lesion size (Figure 6A) only in mouse nrin, 1.0 mg/kg Irin 10.0mg/kg liver lesions. The rat liver foci were refrac-
tory to the effects ofdieldrin (Figures 5B
and 6B). In summary, dieldrin produced an
increase in DNA synthesis in both naive
and foci-containing mouse livers while hav-
ing no such effect in similarly treated rat
livers. This suggests that the hepatic carcino-
genic effects of the dieldrin are uniquely
linked to the physiologic, biochemical, and
metabolic properties ofthe mouse.
Previous studies by Stohs and colleagues
(40) showed that selected chlorinated
hydrocarbon pesticides produced lipid per-
60 oxidation in the liver of treated animals.
3ys Because ofthe significance ofthe potential
role ofoxidative stress in the induction of
cancer as described above, we further
examined dieldrin-treated mice and rats for
hepatic oxidative stress. Using the same
doses of dieldrin and treatment regimens
described, rats and mice were examined for
changes in oxidative damage (DNA oxida-
tion [8-OHdG]) and lipid peroxidation
(MDA), changes in antioxidants (vitamins
E and C, glutathione) and formation of
ROS following subchronic dieldrin treat-
ment. These end points were examined in
both the target tissue (the liver) and in
urine (as a means of assessing total body
oxidative stress). The results from these
studies showed a dieldrin-associated induc-
tion of oxidative stress parameters in
the mouse (Figure 7A). These changes
included an increase in mouse liver MDA
that correlated with dieldrin concentration
and duration of treatment. In addition
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Figure 6. Dieldrin and hepatic focal lesion volume. The effect of dieldrin at three concentrations (0.1, 1.0, and 10
mg/kg) on hepatic focal lesion volume in diethyinitrosamine-induce hepatic foci in male (A) B6C3F1 mouse liver
and (B) F344 rat liver was examined after 7, 30, and 60 days of treatment. Dieldrin produced a dose-dependent
increase in focal volume at the two highest concentrations examined in the mouse but had no effect on hepatic
focal volume inthe rat.
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Figure 7. Selective oxidative stress and dieldrin. The effe(
min E, hepatic 8-OHdG, and urine 8-OHdG) were examinec
treated with 10 mg/kg dieldrin for 7, 14, 28, and 90 days.
mouse liver. A significant decrease in vitamin E concentral
seen in hepatic 8-OHdG levels. In contrast, no changes w
the rat liver.
antioxidant levels in the mouse liver,
specifically vitamin E, showed a dramatic
decrease following dieldrin exposure.
Although an increase in oxidized DNA
adducts was not seen in the mouse liver, 8-
OHdG (the possible result ofdamage and
repair) was seen in urine ofdieldrin-treated
mice. In contrast to the mouse, no increase
in the indicators ofoxidative damage was
seen in dieldrin-treated rat liver or urine
(Figure 7B). Dieldrin reduced hepatic vita-
min E levels in the rat in a dose-responsive
manner. However, because the rat vitamin
E levels were normally at greater concen-
trations than that seen in the mouse, the
effect ofdieldrin on vitamin E in the rat
- Untreated
-{- Vitamin E
p jDieldrin, 10mg/kg
-0- Dieldrin +vitamin E
7 14 28
Treatment duration, days
90
Figure 8. Vitamin E supplementation effects on dield-
rin-induced DNA synthesis in the mouse liver. Vitamin E
(450 mg/kg), dieldrin (10 mg/kg), untreated control, and
dieldrin supplemented with vitamin E were examined
for their effects on the labeling index after 7, 14, 28,
and 90days oftreatment. Dieldrin produced an increase
in hepatocyte labeling that peaked after 14 days of
treatment. Vitamin Ecotreatment ablated this effect.
promotion in the mouse liver. Both naive
and diethylnitrosamine-initiated male
-0- MDA B6C3F1 mice were treated with either 10 B --0-- \itarninE. 40-- Hepatic8-OHdG ppm dieldrin, 450 ppm vitamin E, 450 -00 Urine8-OHdG ppm vitamin E and 10 ppm dieldrin, or an
untreated control diet. Supplementation
with vitamin E prevented the induction of
c DNA synthesis in dieldrin-treated naive
2200 mouse liver (Figure 8) and prevented the
induction ofhepatic lesion growth in pre-
CL 100- -=_ neoplastic mouse liver lesions (42). These
results suggest that the growth stimulatory
effects of dieldrin may be mediated
0- 7 14 28 90 through oxidative stress mechanisms.
An important aspect of these studies Exposure duration, days was to ascertain the overall risk ofhumans
cts of selective oxidative stress parameters (MDA, vita- to dieldrin-induced cancer. Because a
d in male (A) B6C3F1 mouse liver and (B) F344 rat liver potential mechanism for dieldrin cancer
An increase in MDAand urine 8-OHdG was seen in the formation in the mouse liver was deter-
tion was also observed while no significant change was mined to be through nongenotoxic mecha-
ere observed in any ofthese parameters at anytime in nisms involving the selective induction of
oxidative stress, additional comparative
studies were performed in vitro. Hepatocytes
liver appeared quenched by this greater isolated from rat, mouse, and human liver
amount ofnative liver vitamin E, and thus (obtained from autopsy and surgical speci-
dieldrin did not produce the oxidative mens) were placed in primary cultures,
damage observed in the mouse liver (41). treated with dieldrin, and examined for
Based on these observations additional several important end points including
studies were performed to further under- modification ofgap junctional intercellu-
stand the possible link between the lar communication and induction of
induction of oxidative stress and the pro- oxidative stress.
motional effects ofdieldrin in the mouse Dieldrin inhibited gap junctional inter-
liver. Because vitamin E appeared to be cellular communication in mouse hepato-
selectively decreased in the dieldrin- cytes but failed to block communication in
treated mice, additional investigations similarly treated rat and human hepato-
were performed to examine whether sup- cytes (43). The blockage of cell-to-cell
plementation ofvitamin E to the dieldrin communication in the mouse hepatocytes
treatment would reduce dieldrin-induced was concentration- and time-dependent.
DNA synthesis and preneoplastic lesion This inhibition was reversible after removal
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of the dieldrin from the culture medium.
Vitamin E coincubation with the dieldrin
prevented the blockage of cell-to-cell
communication seen with dieldrin alone
(S Bachowski, unpublished result).
In addition, the ability of dieldrin to
induce oxidative stress in cultured mouse,
rat, and human hepatocytes was examined.
Dieldrin, as seen in vivo, produced a dose-
dependent increase in lipid peroxidation
and oxidized DNA bases (8-OHdG) in cul-
tured mouse hepatocytes. Dieldrin did not
induce these changes in similarly treated rat
and human hepatocytes (Figure 9). In
hepatocytes from all three species a decrease
in intracellular vitamin E was seen follow-
ing dieldrin exposure. However, whereas
the vitamin E stores in the human and rat
hepatocytes were much greater than that
seen in the mouse hepatocytes, the reulting
dieldrin-induced decrese in vitamin E in
human and rat liver cells did not produce
oxidative stress. Subsequent studies on
vitamin E levels in liver from rat, mouse,
and humans showed a similar difference in
native vitamin E levels to that seen in the
isolated hepatocytes.
Conclusions
Oxidative stress appears to be an important
factor in a number of human diseases
including the induction ofcancer. Several
chemical carcinogens seem to induce
oxidative stress either indirectly through
modification of cellular antioxidant
defense mechanisms or directly. Dieldrin,
an organochlorine pesticide, causes cancer in
the mouse liver. The induction ofcancer by
dieldrin seems to be through nongenotoxic
mechanisms and may involve the selective
production ofoxidative stress by the dield-
rin in the liver ofmice. In conclusion, the
formation ofROS by toxic agents generally
and chemical carcinogens specifically may
be an important mechanism to consider
when evaluating compound risk.
400 - M Mouse
m Rat
Human
~300
200
o *
MDA ... amin E 'dG 23-DHBA
Figure 9. Dieldrin effects on selective oxidative stress
parameters (MDA, vitamin E levels, 8-OHdG, and oxy-
gen free radical formation [2,3-DHBAI). Dieldrin effects
were examined in rat, mouse, and human hepatocytes
in primary culture. In the mouse, MDA, 8-OHdG, and
2,3-DHBA showed a significant increase after a 24-hr
exposure to dieldrin. In contrast, vitamin E was depleted
to significantly low levels. No changes in these four
parameters were seen in rat and human hepatocytes
treated in a similar manner.
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